However, South Africa's medical regulator, the drug's manufacturer and some of the country's most eminent scientists have all warned against using it to treat coronavirus. It has now become ...
The Dermatological Drugs market in South Africa is forecasted to reach a revenue of US$61.75m in 2024. It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 5.10%, leading to a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback